Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 6:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Autism Spectrum Disorder (ASD)
Interventions: Omega-3 Fatty Acid; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 17 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Rheumatoid Arthritis
Interventions: fish oil, borage seed oil, combination fish oil and borage seed oil; Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 85 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 13
States / cities: Birmingham, Alabama • Trumbull, Connecticut • Boca Raton, Florida + 9 more

Conditions: Prostate Cancer
Interventions: Fish Oil, Vitamin E supplement, Western Diet, Low-Fat Diet, Medical Examination, Dietary Interview, Blood Draw, Radical Prostatectomy; Dietary Supplement · Other · Procedure
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 40 Years to 75 Years · Male only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2018
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Diabetes
Interventions: Lovaza (fish oil); Dietary Supplement
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obesity
Interventions: SFA, MUFA, PUFA-LA, ALA, LCn3; Other
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Liver Disease, Impaired Liver Function, Parenteral Nutrition Associated Liver Disease
Interventions: Omegaven; Drug
Lead sponsor: Children's Medical Center Dallas; Other
Eligibility: 2 Months to 10 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Kidney Stone
Interventions: DASH-Style Diet, Western-Style Diet; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 89 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Heart Failure
Interventions: Glutamine and Fish Oil Supplementation, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 35 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Metastatic Melanoma
Interventions: Taxoprexin; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 13 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Heart Failure
Interventions: Dietary Approaches to Stop Hypertension Diet; Other
Lead sponsor: University of Georgia; Other
Eligibility: 65 Years to 110 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cholestasis of Parenteral Nutrition
Interventions: Smoflipid 20% Lipid Emulsion for Injection, Intralipid, 20% Intravenous Emulsion; Drug
Lead sponsor: Indiana University; Other
Eligibility: Not listed
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Head Trauma
Interventions: Docosahexaenoic Acid (DHA); Dietary Supplement
Lead sponsor: Texas Christian University; Other
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Lupus Erythematosus, Systemic
Interventions: Mediterranean Dietary Pattern, High Fermented Food Dietary Pattern; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Heart Failure
Interventions: Sodium reduction, omega 3 and lycopene supplements, rice bran oil capsules, Generic dietary feedback from; Behavioral · Dietary Supplement
Lead sponsor: Terry Lennie; Other
Eligibility: 21 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 2
States / cities: Lexington, Kentucky • Louisville, Kentucky

Conditions: Healthy Volunteers
Interventions: Supplement; Dietary Supplement
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years to 60 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Depression, Depression, Postpartum
Interventions: Omega-3 Fatty Acids (EPA plus DHA), Supportive psychotherapy, Placebo; Drug · Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Infant Development
Interventions: Docosahexaenoic acid (DHA) and arachidonic acid (ARA), Corn oil placebo; Dietary Supplement
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 351 Days to 379 Days
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pregnancy, Child Development
Interventions: DHA, Sugar pill; Dietary Supplement
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetic Neuropathies
Interventions: Fish Oil Concentrate, 1000 Mg Oral Capsule, Salsalate Oral Tablet; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Iowa City, Iowa • Portland, Oregon

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Capsule + Powder supplementation, stable tracer infusion; Dietary Supplement · Other
Lead sponsor: Texas A&M University; Other
Eligibility: 45 Years to 100 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Osteoarthritis (OA) of the Hip, Osteoarthritis (OA) of the Knee, Osteoarthritis (OA) of the Shoulder, Osteoarthritis, Mild Cognitive Impairment, MCI, Mild Cognitive Impairment (MCI), Dementia
Interventions: Well-formulated ketogenic diet; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 55 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Fairway, Kansas

Conditions: Chronic Venous Leg Ulcers
Interventions: EPA+DHA, placebo; Dietary Supplement · Other
Lead sponsor: Ohio State University; Other
Eligibility: 55 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Amblyopia
Interventions: Docosahexaenoic Acid, Placebo Oral Tablet; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 3 Years to 17 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Eldery People, Cognitive Decline, Memory Decline, DHA CNS Delivery
Interventions: LPC-EPA+DHA capsules containing omega-3 fatty acids EPA and DHA esterified to lysophosphatidylcholine (LPC-EPA+DHA)(Trade name: Lysoveta); Dietary Supplement
Lead sponsor: University of Cincinnati; Other
Eligibility: 55 Years to 82 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Cincinnati, Ohio

Search by objective public record fields.

Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders

Treatment of Rheumatoid Arthritis With Marine and Botanical Oils

Low-Fat Fish Oil Diet for Prostate Cancer Prevention

Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease

Acute Effects of Fats on Satiety and Energy Needs

Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease

Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure

Taxoprexin® Treatment for Advanced Eye Melanoma

Effect of DASH on HF Outcomes Heart Failure Status in Older Adults (DASH HF)

Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates

The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus

Nutrition Intervention to Decrease Symptoms in Patients With Heart Failure

Can Fish Oil and Phytochemical Supplements Mimic Anti-Aging Effects of Calorie Restriction?

Use of Omega-3 Fatty Acids for Perinatal Depression

Effect of Long-Chain Polyunsaturated Fatty Acid Supplementation on Toddler Cognition

Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation

Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy

Fish Oil and HMB Supplementation in COPD

Ketogenic Diet to Reduce Osteoarthritis Pain in MCI

Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older Adults

Docosahexaenoic Acid (DHA) Supplementation in Amblyopia

Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia